Reckitt Benckiser Delivers Solid Q1 Growth in Emerging Markets, Maintains 2025 Outlook

Reckitt’s Q1: Emerging Markets Shine While Core Business Flexes Muscle

Reckitt Benckiser’s first quarter reads like a tale of two consumer landscapes. While developed markets grapple with what CEO Kris Licht diplomatically calls a “challenging macroeconomic outlook,” emerging markets are partying like it’s 1999. Let’s unpack what this means for investors.

The Big Picture: 10.7% Growth Where It Matters

Emerging markets delivered a barnstorming +10.7% LFL growth, contributing £1.04bn to the kitty. Three things stand out:

• China and India firing on all cylinders with double-digit growth
• Durex becoming the condom equivalent of a rockstar in Asian markets
• Dettol bar soap proving Indians really do want squeaky-clean hands

West vs The Rest

Europe’s Gentle Decline (-1.7% LFL)

Pharmacy restocking cycles and nitrile condom rollouts can’t fully offset what looks suspiciously like consumers rationing their Nurofen. Bright spot? Germany and Italy going germ-crazy with Dettol.

North America’s Retailer Chess Game (-0.9% LFL)

Walgreens and CVS playing inventory Jenga with Mucinex stocks while Lysol tries to sanitise its way through supply chain growing pains. Club stores winning, drugstores… not so much.

The Powerbrand Playbook

Core Reckitt’s +3.1% growth hides fascinating category battles:

Germ Protection	+7.5%	Dettol’s washing machine cleaners? Genius
Intimate Wellness	+16.6%	Hyaluronic acid condoms – because why not?

The Elephant in the Room: Essential Home

That -7% LFL decline isn’t just about tough comps. Air Wick’s struggle against private label smells suspiciously like a business needing better perfume. Management’s “we’ll fix it in post-production” H2 recovery narrative? We’re keeping the smelling salts handy.

Looking Ahead: No Panic, Plenty of Metrics

Reckitt’s holding firm on 2025 guidance like a climber with premium-grade carabiners:

• £815m of £1bn buyback already done – bullish signal
• GenAI moving from marketing to R&D – expect robot-developed loo cleaner soon?
• US tariff impacts deemed “immaterial” – supply chain team earning their keep

The Bottom Line

This quarter proves Reckitt’s emerging markets engine can compensate for Western wobbles. With 40% of core revenue now from growth markets and nitrile condoms heading to a bedroom near you, the 2025 outlook looks achievable – if slightly dependent on China’s ongoing love affair with Western hygiene brands.

One to watch: how Essential Home’s potential sale plays out in a jittery market. For now, the Dettol-Durex double act deserves its standing ovation.